The progressive decline of cognitive abilities and memory typical of AD correlates, at the molecular level, with the deposition of amyloid‐β (Aβ) peptide and the hyperphosphorylation of Tau (p‐Tau) protein within the brain (Knopman et al. 2021). This evidence concerns the gene MAPT and Alzheimer disease.